Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease

By sjmartinez • March 8, 2023

Tsitsikas DA, Rowe S, Bosch A, Hui C, Sadasivam N, Palaskas NJ, Pancham S, Rizvi S, Taylor J, Greaves P, Glenthøj A, Hoffmann M, Drasar E, Eleftheriou P. Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease. Br J Haematol. 2023 Mar;200(6):e50-e52. doi: 10.1111/bjh.18638. Epub 2023 Jan 3. PMID: 36594271.

Tags: Hematology/Oncology, Publications

Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan[...]

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies

Li YR, Fang Y, Niu S, Zhu Y, Chen Y, Lyu Z, Zhu E, Tian Y, Huang J, Rezek V, Kitchen S, Hsiai T, Zhou[...]

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Wilky BA, Schwartz GK, Gordon MS, El-Khoueiry AB, Bullock AJ, Henick B, Agulnik M, Singh A, Mahadevan D, Stebbing J, Delepine C, Chand D, Avagyan[...]